LN
Therapeutic Areas
Genenta Science Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Temferon | Glioblastoma Multiforme (unmethylated MGMT promoter) | Phase 1/2 |
Leadership Team at Genenta Science
PP
Pierluigi Paracchi
Chairman and Interim CEO
AD
Alessandro Dotti
Co-Founder and Chief Scientific Officer